ROLE OF DUAL-TASK COST IN PREDICTING FALL RISK AMONG OLDER ADULTS RECEIVING INSTITUTIONAL CARE (NCT07631975) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
ROLE OF DUAL-TASK COST IN PREDICTING FALL RISK AMONG OLDER ADULTS RECEIVING INSTITUTIONAL CARE
Turkey (Türkiye)52 participantsStarted 2026-06-01
Plain-language summary
There is a need for studies that examine the role of dual-task cost in predicting fall risk among older adults receiving institutional care and that develop classification models that can be used in clinical practice. The planned study aims to determine the discriminative ability of dual-task cost in identifying fall risk and to establish clinically meaningful cutoff values. In this respect, the study will both contribute to a more sensitive assessment of fall risk and provide a scientific basis for a low-cost, practical, and applicable screening approach.
Who can participate
Age range
65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Being 65 years of age or older
* Residing in a nursing home or care institution for at least 1 month
* Ability to walk a distance of at least 10 meters
* Ability to ambulate independently with an assistive device (e.g., cane, walker), if needed
* Having a Montreal Cognitive Assessment (MoCA) score of 18 or above
* Ability to understand and execute single- and two-step verbal commands
* Voluntary agreement to participate in the study and providing informed consent
Exclusion Criteria:
* History of stroke or major orthopedic surgery within the past 6 monthsPresence of Parkinson's disease Stage ≥3 (Hoehn \& Yahr) or any other neurological condition significantly affecting gait
* Having a MoCA score below 18
* History of fracture within the past 3 months
* Presence of severe pain affecting gait during test administration (Visual Analog Scale \[VAS\] ≥ 7)
* Uncontrolled hypertension (≥ 180/100 mmHg) or unstable cardiovascular status
* Active vestibular disease or a history of syncope within the past 3 months
* Visual or hearing impairment severe enough to impede test execution
* Inability to walk/ambulate without the physical assistance of another person
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.